Skip to main content

Table 4 Final T and N stages of the cases in the upfront surgery group detected by different imaging modalities

From: The additive role of dynamic contrast-enhanced and diffusion-weighted MR imaging in preoperative staging of breast cancer

Size (T) SM DCE-MRI MRI-DWI Pathology
Tx 3/37 (8.1%) 0/37 0/37 0/37
T0 4/37 (10.8%) 1/37 (2.7%) 14/37 (37.8%) 1/37 (2.7%)
T1 9/37 (24.3%) 7/37 (18.9%) 7/37 (18.9%) 13/37 (35.1%)
T2 18/37 (48.6%) 20/37 (54%) 8/37 (21.6%) 16/37 (43.2%)
T3 3/37 (8.1%) 9/37 (24.3%) 8/37 (21.6%) 6/37 (16.2%)
T4 0/37 0/37 0/37 1/37 (2.7%)
Lymph node (N) SM DCE-MRI MRI-DWI Pathology
Nx 3/37 (8.1%) 8/37(21.6%) 0/37 0/37
N0 22/37 (59.4%) 17/37 (45.9%) 24/37 (64.8%) 22/37 (59.4%)
N1 11/37 (29.7%) 10/37 (27%) 11/37 (29.7%) 11/37 (29.7%)
N2 1/37 (2.7%) 1/37 (2.7%) 1/37 (2.7%) 3/37 (8.1%)
N3 0/37 1/37 (2.7%) 1/37 (2.7%) 1/37 (2.7%)